Reported Earnings • Mar 03
First half 2026 earnings released: AU$0.15 loss per share (vs AU$0.004 loss in 1H 2025) First half 2026 results: AU$0.15 loss per share (further deteriorated from AU$0.004 loss in 1H 2025). Revenue: AU$40.3m (up 40% from 1H 2025). Net loss: AU$20.8m (loss widened AU$20.3m from 1H 2025). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Software industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 170 percentage points per year, which is a significant difference in performance. Price Target Changed • Feb 27
Price target increased by 12% to AU$2.40 Up from AU$2.15, the current price target is an average from 2 analysts. New target price is 33% above last closing price of AU$1.80. Stock is up 49% over the past year. The company posted a net loss per share of AU$0.02 last year. New Risk • Feb 26
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 20% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 20% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$5.4m net loss in 3 years). Shareholders have been diluted in the past year (16% increase in shares outstanding). Aankondiging • Feb 11
Acusensus Limited to Report First Half, 2026 Results on Feb 26, 2026 Acusensus Limited announced that they will report first half, 2026 results on Feb 26, 2026 New Risk • Dec 30
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 8.5% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$3.5m net loss in 3 years). Shareholders have been diluted in the past year (16% increase in shares outstanding). Aankondiging • Dec 16
Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million. Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 6,892,287
Price\Range: AUD 1.5
Discount Per Security: AUD 0.06
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 13,107,713
Price\Range: AUD 1.5
Discount Per Security: AUD 0.06
Transaction Features: Subsequent Direct Listing New Risk • Nov 19
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 28% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 28% per year for the foreseeable future. Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (AU$4.6m net loss in 2 years). Aankondiging • Oct 17
Acusensus Limited, Annual General Meeting, Nov 19, 2025 Acusensus Limited, Annual General Meeting, Nov 19, 2025. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, Australia Major Estimate Revision • Oct 09
Consensus estimates of losses per share improve by 34% The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from AU$81.3m to AU$83.9m. EPS estimate increased from -AU$0.031 per share to -AU$0.021 per share. Software industry in Australia expected to see average net income growth of 23% next year. Consensus price target up from AU$1.39 to AU$2.03. Share price rose 34% to AU$1.74 over the past week. New Risk • Oct 08
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 10% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 10% per year for the foreseeable future. Minor Risk Currently unprofitable and not forecast to become profitable over next 3 years (AU$3.7m net loss in 3 years). Price Target Changed • Oct 03
Price target increased by 13% to AU$1.48 Up from AU$1.31, the current price target is an average from 2 analysts. New target price is 9.3% above last closing price of AU$1.35. Stock is up 65% over the past year. The company is forecast to post a net loss per share of AU$0.024 next year compared to a net loss per share of AU$0.02 last year. Reported Earnings • Aug 27
Full year 2025 earnings released: AU$0.02 loss per share (vs AU$0.012 loss in FY 2024) Full year 2025 results: AU$0.02 loss per share (further deteriorated from AU$0.012 loss in FY 2024). Revenue: AU$59.4m (up 20% from FY 2024). Net loss: AU$2.62m (loss widened 72% from FY 2024). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Software industry in Australia. Aankondiging • Aug 15
Acusensus Limited to Report Fiscal Year 2025 Results on Aug 26, 2025 Acusensus Limited announced that they will report fiscal year 2025 results on Aug 26, 2025 New Risk • Mar 04
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 18% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 18% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$3.8m net loss in 2 years). Significant insider selling over the past 3 months (AU$1.5m sold). New Risk • Mar 01
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: AU$160.9m (US$99.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$471k net loss in 2 years). Significant insider selling over the past 3 months (AU$1.5m sold). Market cap is less than US$100m (AU$160.9m market cap, or US$99.8m). New Risk • Feb 28
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: AU$1.8m Forecast net loss in 2 years: AU$471k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$471k net loss in 2 years). Significant insider selling over the past 3 months (AU$1.5m sold). Aankondiging • Feb 02
Acusensus Limited to Report First Half, 2025 Results on Feb 27, 2025 Acusensus Limited announced that they will report first half, 2025 results on Feb 27, 2025 New Risk • Jan 11
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Significant insider selling over the past 3 months (AU$1.5m sold). Market cap is less than US$100m (AU$149.0m market cap, or US$91.6m). Aankondiging • Dec 20
Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 2.000001 million. Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 2.000001 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 2,222,223
Price\Range: AUD 0.9
Discount Per Security: AUD 0.0405 Aankondiging • Dec 07
Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 10.000001 million. Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 10.000001 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 11,111,112
Price\Range: AUD 0.9
Discount Per Security: AUD 0.0405
Transaction Features: Subsequent Direct Listing Aankondiging • Oct 17
Acusensus Limited, Annual General Meeting, Nov 21, 2024 Acusensus Limited, Annual General Meeting, Nov 21, 2024. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, melbourne Australia New Risk • Sep 02
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: AU$1.5m Forecast net loss in 3 years: AU$1.2m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$1.2m net loss in 3 years). Market cap is less than US$100m (AU$87.2m market cap, or US$59.0m). Recent Insider Transactions • Jun 13
Independent Non-Executive Director recently bought AU$75k worth of stock On the 11th of June, Susan Klose bought around 125k shares on-market at roughly AU$0.60 per share. This transaction increased Susan's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Price Target Changed • Feb 29
Price target increased by 20% to AU$1.30 Up from AU$1.08, the current price target is provided by 1 analyst. New target price is 59% above last closing price of AU$0.82. Stock is up 9.3% over the past year. The company posted earnings per share of AU$0.00049 last year. New Risk • Feb 27
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (AU$96.1m market cap, or US$62.9m). Aankondiging • Oct 10
Acusensus Limited Appoints Michael Lawrence Giuffrida as Director Acusensus Limited announced the appointment of Michael Lawrence Giuffrida as an independent non-executive Director, effective from October 9, 2023. Mr. Giuffrida's appointment follow the resignation of thomas patterson from the board in june 2023. Mr. Giuffrida is an entrepreneur with over 25 year of experience, having co=founded and been the CEO pf a human resource technology company, Acendre Pty Ltd. in 1997. Under Mike's leadership, acendre subsequently established a presence in the US, including in the US federal government market, before leading a process to identify a mojority growth investment partener for Acendre and subsequent acquisition of a US based HR technology company. At the end of 2019, Mike led a successfull trasition to a US based CEO to head up Acendre's next phase of growth, which enabled Mike to return to australia full time with his family. Reported Earnings • Aug 26
Full year 2023 earnings released Full year 2023 results: Revenue: AU$42.0m (up 47% from FY 2022). Net income: AU$55.0k (down 96% from FY 2022). Profit margin: 0.1% (down from 5.0% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Software industry in Australia. New Risk • Aug 25
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Market cap is less than US$100m (AU$88.3m market cap, or US$56.6m). Aankondiging • Aug 24
Acusensus Limited, Annual General Meeting, Nov 16, 2023 Acusensus Limited, Annual General Meeting, Nov 16, 2023. Buying Opportunity • Jul 12
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 7.2%. The fair value is estimated to be AU$4.12, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 70% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 37% in 2 years. Earnings is forecast to grow by 19% in the next 2 years. Reported Earnings • Feb 24
First half 2023 earnings released First half 2023 results: AU$0.01 loss per share. Net loss: AU$262.8k (flat on 1H 2022). Valuation Update With 7 Day Price Move • Feb 23
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to AU$3.89, the stock trades at a trailing P/E ratio of 68.5x. Average trailing P/E is 53x in the Software industry in Australia. Board Change • Jan 12
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.